Michael Golatta
Overview
Explore the profile of Michael Golatta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai L, Golatta M, Sidey-Gibbons C, Barr R, Pfob A
Arch Gynecol Obstet
. 2025 Jan;
PMID: 39883137
Purpose: Artificial Intelligence models based on medical (imaging) data are increasingly developed. However, the imaging software on which the original data is generated is frequently updated. The impact of updated...
2.
Vogel-Minea C, Bader W, Blohmer J, Duda V, Eichler C, Fallenberg E, et al.
Ultraschall Med
. 2025 Jan;
PMID: 39809439
Breast ultrasound has been established for many years as an important method in addition to mammography for clarifying breast findings. The goal of the Best Practice Guidelines Part III of...
3.
Vogel-Minea C, Bader W, Blohmer J, Duda V, Eichler C, Fallenberg E, et al.
Ultraschall Med
. 2025 Jan;
PMID: 39809438
Breast ultrasound has been established for many years as an important method in addition to mammography for clarifying breast findings. The goal of the Best Practice Guidelines Part III of...
4.
Togawa R, Dahm H, Feisst M, Sinn P, Hennigs A, Nees J, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766168
The pretherapeutic assessment of axillary lymph node status is crucial in staging early breast cancer patients, significantly influencing their further treatment and prognosis. According to current guidelines, patients with clinically...
5.
Cai L, Deutsch T, Sidey-Gibbons C, Kobel M, Riedel F, Smetanay K, et al.
JCO Clin Cancer Inform
. 2024 Dec;
8:e2400010.
PMID: 39715466
Purpose: Toxicity to systemic cancer treatment represents a major anxiety for patients and a challenge to treatment plans. We aimed to develop machine learning algorithms for the upfront prediction of...
6.
Reimer T, Stachs A, Veselinovic K, Kuhn T, Heil J, Polata S, et al.
N Engl J Med
. 2024 Dec;
392(11):1051-1064.
PMID: 39665649
Background: Whether surgical axillary staging as part of breast-conserving therapy can be omitted without compromising survival has remained unclear. Methods: In this prospective, randomized, noninferiority trial, we investigated the omission...
7.
Togawa R, Riedel F, Feisst M, Fastner S, Gomez C, Hennigs A, et al.
Insights Imaging
. 2024 Aug;
15(1):196.
PMID: 39112749
Background: Preoperative evaluation of axillary lymph node status is crucial for the selection of both systemic and surgical treatment in early breast cancer. This study assessed the particular role of...
8.
Riedel F, Hahn M, Bader W, Schafgen B, Fastner S, Hennigs A, et al.
Breast Care (Basel)
. 2024 May;
19(2):87-94.
PMID: 38765898
Introduction: Pre-therapeutic histologic diagnosis through image-guided core needle biopsy (CNB) or vacuum-assisted biopsy (VAB) for suspicious breast findings is a standard procedure. Despite the moderate risk of bleeding, a significant...
9.
Krug D, Vladimirova V, Untch M, Kuhn T, Schneeweiss A, Denkert C, et al.
Breast
. 2024 Feb;
74:103701.
PMID: 38422624
Background: Neoadjuvant chemotherapy (NACT) is routinely used for patients with triple-negative breast cancer (TNBC). Upfront breast-conserving therapy (BCT) consisting of breast-conserving surgery (BCS) and adjuvant radiotherapy (RT) has been shown...
10.
Vinsensia M, Schaub R, Meixner E, Hoegen P, Arians N, Forster T, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254756
Methods: We retrospectively analyzed 118 women with breast cancer who underwent PMRT following an IBR between 2010 and 2022. Patients were treated with PMRT of 50.0-50.4 Gy in 25-28 fractions....